Katy White
Impact in
- Dermatology top 5%
- Dermatology and Skin Diseases
-
- Psoriasis: Treatment and Pathogenesis
Papers in
-
- Psoriasis: Treatment and Pathogenesis 8
-
- Spondyloarthritis Studies and Treatments 6
- Rheumatoid Arthritis Research and Therapies 2
- Systemic Lupus Erythematosus Research 2
- Co-authors
- Andrew Blauvelt (4 shared papers)G Chouinard (2 shared papers)Veerle Vanvoorden (2 shared papers)S. Rasmussen (2 shared papers)John H. Greist (2 shared papers)Kristian Reich (2 shared papers)Christopher L. Cioffi (2 shared papers)Andreas Pinter (2 shared papers)
- Journals
- Annals of the Rheumatic Diseases (3 papers)Journal of the American Academy of Dermatology (2 papers)Lara D. Veeken (2 papers)RMD Open (1 paper)The Lancet (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Katy White
13 papers receiving 403 citations
Katy White's Hit Papers
Peers
Comparison fields: 5 of 54
- Dermatology 102
- Immunology 192
- Clinical Psychology 173
- Experimental and Cognitive Psychology 92
- Rheumatology 55
Countries citing papers authored by Katy White
This map shows the geographic impact of Katy White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy White more than expected).
Fields of papers citing papers by Katy White
This network shows the impact of papers produced by Katy White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy White. The network helps show where Katy White may publish in the future.
Co-authors
The 25 scholars most cited alongside Katy White, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial Hit paper breakdown → | 2021 | 170 |
| 2 | Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. | 1990 | 108 |
| 3 | 1995 | 97 | |
| 4 | 2023 | 28 | |
| 5 | 2024 | 11 | |
| 6 | 2021 | 6 | |
| 7 | 2025 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2025 | 0 |
About Katy White
Katy White is a scholar working on Immunology, Rheumatology, Ophthalmology, Dermatology and Clinical Psychology, having authored 14 papers that have together received 430 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (8 papers), Spondyloarthritis Studies and Treatments (6 papers), Ocular Diseases and Behçet’s Syndrome (4 papers), Dermatology and Skin Diseases (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Obsessive-Compulsive Spectrum Disorders (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Dermatology (102 citations), Immunology (192 citations), Clinical Psychology (173 citations), Experimental and Cognitive Psychology (92 citations) and Rheumatology (55 citations). Katy White has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Andrew Blauvelt, G Chouinard, Veerle Vanvoorden, S. Rasmussen, John H. Greist, Kristian Reich, Christopher L. Cioffi, Andreas Pinter, Ronald Vender and James G. Krueger. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology, Lara D. Veeken, RMD Open and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.